Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10364-9. doi: 10.1073/pnas.162356399. Epub 2002 Jul 22.

Abstract

Nitric oxide (NO(*)) is mutagenic and, under appropriate conditions of exposure, also induces apoptosis in many in vitro and in vivo experimental models. Biochemical and cellular mechanisms through which NO(*) induces apoptosis are incompletely understood, but involve p53/mitochondria-dependent signaling pathways. In this study, we exposed human lymphoblastoid cells harboring either wild-type (TK6 cells) or mutant p53 (WTK-1 cells) to NO(*), delivered by diffusion through Silastic tubing. Cells were exposed for 2 h at constant rates of 100-533 nM/s, similar to levels estimated to occur in vivo in inflamed tissues. DNA double-strand breaks and fragmentation detected 8-48 h after NO(*) treatment were more extensive in TK6 cells than in WTK-1 cells, whereas NO(*)-induced mutant fractions in both HPRT and TK1 genes were significantly lower in TK6 cells than in WTK-1 cells (P < 0.01-0.05). Treatment of TK6 cells with NO(*) caused extensive apoptosis, but this response was delayed and greatly reduced in magnitude in WTK-1 cells. Mitochondrial membrane depolarization and cytochrome c release were induced in both cell types. However, elevation of apoptotic protease-activating factor-1 (Apaf-1) protein and reduction of X-chromosome-linked inhibitor of apoptosis (XIAP) protein were observed only in TK6 cells. These results indicate that p53 status is an important modulator of NO(*)-induced mutagenesis and apoptosis, and suggest that levels of the Apaf-1 and XIAP proteins, but not mitochondrial depolarization and cytochrome c release, are regulated by p53 in these human lymphoblastoid cells. Thus, Apaf-1 and XIAP may play important roles in the regulation of p53-mediated apoptotic responses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apoptosis*
  • Apoptotic Protease-Activating Factor 1
  • Cytochrome c Group / metabolism
  • DNA Damage
  • DNA Fragmentation
  • Hematopoietic Stem Cells
  • Humans
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / physiology
  • Jurkat Cells
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondria / physiology
  • Mutagenesis
  • Mutagens / pharmacology*
  • Nitric Oxide / pharmacology*
  • Protein Biosynthesis
  • Proteins*
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*
  • X-Linked Inhibitor of Apoptosis Protein

Substances

  • APAF1 protein, human
  • Apoptotic Protease-Activating Factor 1
  • Cytochrome c Group
  • Mutagens
  • Proteins
  • Tumor Suppressor Protein p53
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human
  • Nitric Oxide